# Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone

> **NCT00458796** · NA · TERMINATED · sponsor: **University of Leeds** · enrollment: 1500 (estimated)

## Conditions studied

- Breast Cancer
- Hypercalcemia of Malignancy
- Metastatic Cancer
- Musculoskeletal Complications
- Pain

## Interventions

- **DRUG:** zoledronic acid
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT00458796
- **Lead sponsor:** University of Leeds
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 1500 (ESTIMATED)
- **Why stopped:** Lower than expected recruitment
- **Last updated:** 2022-05-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00458796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00458796, "Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00458796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*